Stevanato Group S.p.A.

STVN Healthcare Medical Instruments & Supplies

Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.

Revenue
+5.91%
EPS
+17.5%
Free cash flow
+4,089.9%
Total debt
+2.85%

Quarter to September 2026, against a year earlier

13.12 0.32 −2.38%
Market cap
$3.6B
P/E
22.4×
Fwd P/E
30.2×
Dividend yield
0.48%
F-score
5/9
Altman Z
4.48
Beneish M
−2.79
Dividend safety
63/100

Stevanato Group S.p.A. (STVN) Free cash flow

Alert me on Free cash flow

Stevanato Group S.p.A.'s free cash flow for fiscal 2025 was $14.6M, compared with −$167.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$8.8M. Over the past ten years it has ranged from −$363.8M (fiscal 2023) to $68.2M (fiscal 2020); the current reading is higher than 57% of that period. Stevanato Group S.p.A. ranks 44th of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $14.6M —
FY2024 −$167.3M —
FY2023 −$363.8M —
FY2022 −$147.2M —
FY2021 $25.2M (62.98%)
FY2020 $68.2M 43.04%
FY2019 $47.6M —

Quarterly newest first

Period Free cash flow Change
Sep 2026 $25.2M —
Jun 2026 −$39.1M —
Mar 2026 $5.9M —
Dec 2025 −$778.5K —
23 more quarters

Against its own ten years

Low −$363.8M High $68.2M
Ten-year median $14.6M
Current reading's percentile 57

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on STVN